The Tumor Microenvironment “Big Tent” series continues (part 4)

Astra Zenenca, Bristol Myers Squibb, CSF1R, Halozyme, IDO, immunotherapy, Merck, TAMs, TGFbeta, tumor microenvironment, tumor stroma

The SugarCone Blog is brought to you by SugarCone Biotech Consulting - Click to learn more about what we can do for your company.

 

The Tumor Microenvironment (TME) series to date is assembled here http://www.sugarconebiotech.com/?s=big+tent containing parts 1-3

I’m happy to point you to the most recent content, posted on Slideshare: http://www.slideshare.net/PaulDRennert/im-vacs-2015-rennert-v2

In this deck I review the challenges of the TME particularly with reference to Pancreatic and Ovarian cancers. A few targets are shown below.

Feedback most welcome.

Screen Shot 2015-08-27 at 7.20.21 AM